Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
2.
Spine J ; 20(7): 998-1024, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32333996

RESUMO

BACKGROUND CONTEXT: The North American Spine Society's (NASS) Evidence Based Clinical Guideline for the Diagnosis and Treatment of Low Back Pain features evidence-based recommendations for diagnosing and treating adult patients with nonspecific low back pain. The guideline is intended to reflect contemporary treatment concepts for nonspecific low back pain as reflected in the highest quality clinical literature available on this subject as of February 2016. PURPOSE: The purpose of the guideline is to provide an evidence-based educational tool to assist spine specialists when making clinical decisions for adult patients with nonspecific low back pain. This article provides a brief summary of the evidence-based guideline recommendations for diagnosing and treating patients with this condition. STUDY DESIGN: This is a guideline summary review. METHODS: This guideline is the product of the Low Back Pain Work Group of NASS' Evidence-Based Clinical Guideline Development Committee. The methods used to develop this guideline are detailed in the complete guideline and technical report available on the NASS website. In brief, a multidisciplinary work group of spine care specialists convened to identify clinical questions to address in the guideline. The literature search strategy was developed in consultation with medical librarians. Upon completion of the systematic literature search, evidence relevant to the clinical questions posed in the guideline was reviewed. Work group members utilized NASS evidentiary table templates to summarize study conclusions, identify study strengths and weaknesses, and assign levels of evidence. Work group members participated in webcasts and in-person recommendation meetings to update and formulate evidence-based recommendations and incorporate expert opinion when necessary. The draft guideline was submitted to an internal and external peer review process and ultimately approved by the NASS Board of Directors. RESULTS: Eighty-two clinical questions were addressed, and the answers are summarized in this article. The respective recommendations were graded according to the levels of evidence of the supporting literature. CONCLUSIONS: The evidence-based clinical guideline has been created using techniques of evidence-based medicine and best available evidence to aid practitioners in the diagnosis and treatment of adult patients with nonspecific low back pain. The entire guideline document, including the evidentiary tables, literature search parameters, literature attrition flowchart, suggestions for future research, and all of the references, is available electronically on the NASS website at https://www.spine.org/ResearchClinicalCare/QualityImprovement/ClinicalGuidelines.aspx.


Assuntos
Dor Lombar , Medicina Baseada em Evidências , Humanos , Dor Lombar/diagnóstico , Dor Lombar/terapia , Coluna Vertebral
3.
J Vasc Surg ; 50(5): 1170-2, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19782513

RESUMO

We report the case of a 70-year-old male with a complication of misplacement of a vena cava filter into the spinal canal. This likely happened as a result of penetration of the wire and filter sheath through the iliac vein or vena cava into the retroperitoneum, vertebral foramina, and spinal canal at the level of L2 and L3. Due to the patient's condition, the filter was not removed and no neurologic symptoms have occurred. This represents the first reported case of a filter deployment into the spinal canal. Although placement of vena cava filters is a relatively safe procedure, complications are seen commonly due to the large number of procedures performed. Spinal complications, however, are rarely reported. This is the first reported case of the inadvertent placement of a vena cava filter into the spinal canal.


Assuntos
Cateterismo/efeitos adversos , Erros Médicos , Canal Medular , Filtros de Veia Cava/efeitos adversos , Veia Cava Inferior/lesões , Idoso , Cateterismo/instrumentação , Humanos , Masculino , Flebografia , Radiografia Intervencionista , Canal Medular/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Veia Cava Inferior/diagnóstico por imagem
4.
J Neurosurg ; 111(3): 497-503, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19199506

RESUMO

OBJECT: The authors report novel imaging findings associated with the treatment of sorafenib (Nexavar) and sunitinib (Sutant), 2 agents used in the treatment of advanced metastatic disease. METHODS: Patients with renal cell and breast carcinoma metastases to the brain were identified from the prospective database at the Penn State Hershey Medical Center and Penn State Cancer Institute. RESULTS: Four patients who received sorafenib or sunitinib after surgical or radiosurgical treatment of their metastases were identified from the database. Clinical and/or radiographic changes consisting of seizures and cognitive or motor changes were described, associated with an increase in peritumoral edema and enhancement. These findings were observed to improve with discontinuation of the medications. CONCLUSIONS: The administration of sorafenib and sunitinib in patients with metastatic breast and renal cell carcinoma may lead to reversible clinical and imaging changes following surgical or radiosurgical treatment of their brain lesions. The authors hypothesize that leakage of the drug across a locally impaired blood-brain barrier contributes to peritumoral edema and inflammation, which may be erroneously interpreted as disease progression.


Assuntos
Antineoplásicos/efeitos adversos , Benzenossulfonatos/efeitos adversos , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/secundário , Encéfalo/patologia , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Carcinoma de Células Renais/tratamento farmacológico , Carcinoma de Células Renais/patologia , Indóis/efeitos adversos , Neoplasias Renais/tratamento farmacológico , Neoplasias Renais/patologia , Imageamento por Ressonância Magnética , Piridinas/efeitos adversos , Pirróis/efeitos adversos , Idoso , Edema Encefálico/induzido quimicamente , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Niacinamida/análogos & derivados , Compostos de Fenilureia , Estudos Prospectivos , Convulsões/induzido quimicamente , Sorafenibe , Sunitinibe
5.
Pediatr Neurosurg ; 44(3): 221-3, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18354262

RESUMO

We present the case of a 17-month-old girl with an untreated Chiari I malformation who developed radiographic progression of syringomyelia over a 23-month period. The patient presented with initial symptoms of airway difficulties and gait ataxia, which did not progress clinically over this period of observation, despite recommendations for surgical decompression. At 17 months, there was a region of T(2) hyperintensity which progressed to become a syrinx within 3 months, enlarging over serial imaging studies. This is the first published report of radiographic progression from a 'presyrinx' state of T(2) hyperintensity to syringomyelia in a pediatric patient with untreated Chiari I malformation.


Assuntos
Malformação de Arnold-Chiari/diagnóstico por imagem , Vértebras Cervicais/diagnóstico por imagem , Siringomielia/diagnóstico por imagem , Malformação de Arnold-Chiari/complicações , Pré-Escolar , Progressão da Doença , Feminino , Humanos , Radiografia , Siringomielia/complicações
8.
Exp Neurol ; 180(2): 167-71, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12684030

RESUMO

Olfactory ensheathing cells (OEC) constitute a specialized population of glia that accompany primary olfactory axons and have been reported to facilitate axonal regeneration after spinal cord injury in vivo. In the present report we describe OEC neurotrophic factor expression and neurotrophic properties of OECs in vitro. Investigation of the rat olfactory system during development and adulthood by radioactive in situ hybridization revealed positive labeling in the olfactory nerve layer for the neurotrophic molecules S-100beta, CNTF, BMP-7/OP-1, and artemin, as well as for the neurotrophic factor receptors RET and TrkC. Ribonuclease protection assay of cultured OEC revealed expression of NGF, BDNF, GDNF, and CNTF mRNA, while NT3 and NT4 mRNA were not detectable. In vitro bioassays of neurotrophic activity involved coculturing of adult OEC with embryonic chick ganglia and demonstrated increased neurite outgrowth from sympathetic, ciliary, and Remak's ganglia. However, when culturing the ganglia with OEC-conditioned medium, neurite outgrowth was not stimulated to any detectable extent. Our results suggest that the neurotrophic properties of OEC may involve secretion of neurotrophic molecules but that cellular interactions are crucial.


Assuntos
Proteínas de Drosophila , Fatores de Crescimento Neural/biossíntese , Neuroglia/citologia , Neuroglia/metabolismo , Nervo Olfatório/citologia , Nervo Olfatório/metabolismo , Animais , Bioensaio , Comunicação Celular/fisiologia , Células Cultivadas , Embrião de Galinha , Técnicas de Cocultura , Meios de Cultivo Condicionados/farmacologia , Gânglios/citologia , Gânglios/embriologia , Receptores de Fator Neurotrófico Derivado de Linhagem de Célula Glial , Hibridização In Situ , Fatores de Crescimento Neural/genética , Neuritos/efeitos dos fármacos , Neuritos/fisiologia , Ensaios de Proteção de Nucleases , Bulbo Olfatório/citologia , Bulbo Olfatório/embriologia , Proteínas Proto-Oncogênicas/biossíntese , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-ret , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Receptores Proteína Tirosina Quinases/biossíntese , Receptores Proteína Tirosina Quinases/genética , Receptor trkC/biossíntese , Receptor trkC/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA